SNDX - Syndax Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$41.50
DETAILS
HIGH:
$46.00
LOW:
$37.00
MEDIAN:
$41.50
CONSENSUS:
$41.50
UPSIDE:
108.54%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 172.4 | 23.7 | 0 | 0 | 139.7 | 1.5 | 1.5 | 1.5 | 2.1 | 1.2 | 0.6 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 7.0 | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Gross Profit | 165.4 | 22.9 | 0 | 0 | 139.7 | 1.5 | 1.5 | 1.5 | 2.1 | 1.2 | 0.6 | 0 | 0 | 0 | (0.1) |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 258.8 | 241.6 | 163.0 | 118.5 | 88.2 | 50.4 | 43.0 | 60.1 | 48.2 | 31.7 | 9.5 | 10.2 | 3.2 | 5.2 | 6.1 |
| SG&A Expenses | 179.7 | 120.9 | 66.9 | 33.3 | 25.2 | 22.5 | 16.1 | 17.3 | 15.9 | 13.3 | 11.6 | 11.2 | 5.4 | 3.5 | 3.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | 0.0 | 0 | (0.0) | 0 |
| Operating Expenses | 438.5 | 362.5 | 230.0 | 151.8 | 113.5 | 72.9 | 59.1 | 77.4 | 64.1 | 45.0 | 21.1 | 21.3 | 8.6 | 8.7 | 9.6 |
| Operating Income | |||||||||||||||
| Operating Income | (273.1) | (339.7) | (230.0) | (151.8) | 26.2 | (71.4) | (57.5) | (75.9) | (62.0) | (43.8) | (20.5) | (21.3) | (8.6) | (8.7) | (9.6) |
| Interest Expense | 33.8 | 4.9 | 0.2 | 3.1 | 1.9 | 2.4 | 0 | 1.9 | 1.4 | 1.0 | 1.6 | 0 | 0 | 0 | 2.0 |
| Interest Income | 22.7 | 26.1 | 21.2 | 5.9 | 0.4 | 0.8 | 1.6 | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 |
| Profitability | |||||||||||||||
| EBITDA | (251.6) | (313.8) | (209.1) | (146.2) | 26.9 | (70.3) | (55.6) | (73.9) | (61.9) | (43.7) | (20.5) | (21.3) | (8.6) | (5.3) | (11.1) |
| EBIT | (251.6) | (313.8) | (209.2) | (146.2) | 26.8 | (70.8) | (56.0) | (74.0) | (62.0) | (43.8) | (20.5) | (21.3) | (8.6) | (5.3) | (11.1) |
| Income Before Tax | (285.4) | (318.8) | (209.4) | (149.3) | 24.9 | (73.2) | (56.0) | (74.0) | (60.8) | (44.5) | (24.1) | (19.8) | (14.2) | (10.0) | (13.1) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.1) | 0 | 0 | 0 | 0 | 0 |
| Net Income | (285.4) | (318.8) | (209.4) | (149.3) | 24.9 | (73.1) | (56.0) | (74.0) | (60.8) | (44.5) | (24.1) | (19.8) | (14.2) | (10.0) | (13.1) |
| Per Share Data | |||||||||||||||
| EPS (Basic) | -3.29 | -3.73 | -2.98 | -2.46 | 0.48 | -1.77 | -1.84 | -2.92 | -2.90 | -3.04 | -4.31 | -2.07 | -1.77 | -0.14 | – |
| EPS (Diluted) | -3.29 | -3.73 | -2.98 | -2.46 | 0.48 | -1.77 | -1.84 | -2.92 | -2.90 | -3.04 | -4.31 | -2.07 | -1.77 | -0.14 | – |
| Shares Outstanding | 86.6 | 85.6 | 70.4 | 60.8 | 52.1 | 41.3 | 30.5 | 25.4 | 21.0 | 14.6 | 5.6 | 9.6 | 8.0 | 70.3 | 619,958 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 134.9 | 154.1 | 295.4 | 74.4 | 222.0 | 115.2 | 24.6 | 33.8 | 35.2 | 23.8 |
| Short-Term Investments | 259.1 | 428.8 | 282.2 | 410.0 | 224.9 | 177.8 | 35.2 | 47.1 | 94.8 | 81.5 |
| Net Receivables | 38.0 | 13.9 | 1.2 | 4.1 | 0.4 | 0.2 | 0.1 | 0.3 | 0.4 | 0.3 |
| Inventory | 32.8 | 0.4 | 0 | 0 | 0 | 0 | 0 | 1.1 | (1.4) | 2.4 |
| Other Current Assets | 63.3 | (2.0) | 0.1 | 0.1 | 0.3 | 0.5 | 2.1 | 1.8 | 1.3 | 0.6 |
| Total Current Assets | 528.1 | 603.1 | 580.9 | 489.8 | 448.4 | 298.9 | 62.3 | 83.3 | 133.4 | 108.5 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 1.5 | 2.0 | 1.5 | 1.1 | 1.3 | 0.5 | 1.0 | 0.4 | 0.3 | 0.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 119.5 | 29.8 | 5.5 | 0 | 0 | 0.1 | 0 | 3.2 | 0 |
| Other Non-Current Assets | 0.1 | 0.2 | 0.7 | 0.9 | 0 | 1.3 | 0.1 | 0.2 | 0.2 | 0.2 |
| Total Non-Current Assets | 1.6 | 121.8 | 32.0 | 7.5 | 1.3 | 1.7 | 1.2 | 0.6 | 3.7 | 0.5 |
| Total Assets | 529.7 | 724.8 | 612.9 | 497.2 | 449.7 | 300.6 | 63.5 | 83.9 | 137.2 | 109.0 |
| Current Liabilities | ||||||||||
| Account Payables | 16.6 | 11.6 | 10.0 | 4.3 | 5.7 | 3.5 | 6.2 | 1.4 | 2.2 | 2.4 |
| Short-Term Debt | 0.5 | 12.1 | 0 | 0 | 0 | 2.3 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 1.5 | 1.5 | 1.5 | 1.6 | 1.2 |
| Other Current Liabilities | 103.1 | 79.3 | 35.9 | 6.5 | 6.2 | 3.7 | 7.4 | 10.3 | 9.6 | 5.1 |
| Total Current Liabilities | 120.1 | 103.5 | 58.1 | 29.1 | 20.7 | 18.9 | 18.4 | 16.1 | 15.8 | 10.4 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 345.0 | 331.6 | 0 | 0 | 19.9 | 17.8 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (1.1) | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.3 |
| Total Non-Current Liabilities | 345.0 | 333.1 | 0.6 | 0.7 | 20.6 | 29.6 | 13.6 | 14.8 | 17.1 | 14.5 |
| Total Liabilities | 465.1 | 436.7 | 58.7 | 29.8 | 41.3 | 48.4 | 31.9 | 30.9 | 32.9 | 24.9 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,506.6) | (1,221.2) | (902.4) | (693.0) | (543.7) | (568.6) | (495.5) | (439.4) | (366.1) | (305.3) |
| Accumulated Other Comprehensive Income | 0.5 | 0.2 | 0.2 | (0.8) | 0.0 | (0.0) | 0 | (0.0) | (0.1) | 0.1 |
| Total Stockholders' Equity | 64.6 | 288.1 | 554.2 | 467.4 | 408.4 | 252.2 | 31.6 | 53.0 | 104.3 | 84.1 |
| Total Liabilities & Equity | 529.7 | 724.8 | 612.9 | 497.2 | 449.7 | 300.6 | 63.5 | 83.9 | 137.2 | 109.0 |
| Debt Metrics | ||||||||||
| Total Debt | 346.5 | 345.7 | 1.6 | 1.2 | 21.0 | 20.5 | 0.9 | 0 | 0 | 0 |
| Net Debt | 211.6 | 191.7 | (293.8) | (73.2) | (201.0) | (94.7) | (23.7) | (33.8) | (35.2) | (23.8) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (285.4) | (318.8) | (209.4) | (149.3) | 24.9 | (73.2) | (56.0) | (74.0) | (60.8) | (44.5) |
| Depreciation & Amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Stock-Based Compensation | 47.5 | 43.0 | 31.0 | 16.0 | 13.3 | 9.1 | 6.0 | 6.2 | 5.5 | 4.7 |
| Change in Working Capital | (79.3) | 13.3 | 31.9 | 1.7 | (9.6) | (7.9) | (0.2) | (0.3) | 7.7 | 2.9 |
| Other Non-Cash Items | (5.7) | (12.4) | (14.1) | (2.0) | 0.2 | 0.7 | 0.4 | 0.0 | 0.0 | 0.0 |
| Operating Cash Flow | (323.0) | (274.9) | (160.6) | (133.7) | 29.1 | (71.3) | (50.6) | (68.5) | (47.4) | (35.2) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.2) | 0 | 0 | (0.2) | (0.1) | 0 | 0 | (0.2) | (0.1) | (0.3) |
| Acquisitions | 0 | 0 | 0 | 0.2 | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (195.8) | (557.1) | (354.6) | (495.3) | (294.7) | (278.9) | (104.0) | (78.8) | (152.3) | (158.3) |
| Sales/Maturities of Investments | 486.0 | 337.3 | 472.2 | 308.9 | 254.0 | 136.4 | 116.8 | 130.4 | 135.3 | 140.3 |
| Other Investing Activities | 0 | 0 | 0 | 0.2 | (0.0) | 0 | 0.0 | 0.1 | 0.0 | (0.1) |
| Investing Cash Flow | 290.0 | (219.8) | 117.6 | (186.2) | (40.9) | (142.5) | 12.8 | 51.4 | (17.0) | (18.4) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | (21.0) | 0 | 19.7 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.6) |
| Other Financing Activities | 0 | 343.7 | 6.0 | 11.9 | 32.1 | 6.6 | 0.4 | 0.2 | 0.4 | 4.7 |
| Financing Cash Flow | 13.7 | 353.4 | 264.1 | 172.3 | 118.5 | 304.4 | 28.6 | 15.7 | 75.7 | 54.2 |
| Cash Position | ||||||||||
| Net Change in Cash | (19.3) | (141.3) | 221.1 | (147.6) | 106.7 | 90.6 | (9.3) | (1.4) | 11.3 | 0.7 |
| Cash at Beginning | 154.3 | 295.6 | 74.5 | 222.1 | 115.4 | 24.7 | 34.0 | 35.4 | 23.8 | 23.2 |
| Cash at End | 135.0 | 154.3 | 295.6 | 74.5 | 222.1 | 115.4 | 24.7 | 34.0 | 35.2 | 23.8 |
| Free Cash Flow | (323.2) | (274.9) | (160.6) | (133.9) | 29.0 | (71.3) | (50.6) | (68.7) | (47.5) | (35.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 172.4 | 23.7 | 0 | 0 | 139.7 | 1.5 | 1.5 | 1.5 | 2.1 | 1.2 | 0.6 | 0 | 0 | 0 | 0 |
| Gross Profit | 165.4 | 22.9 | 0 | 0 | 139.7 | 1.5 | 1.5 | 1.5 | 2.1 | 1.2 | 0.6 | 0 | 0 | 0 | (0.1) |
| Operating Income | (273.1) | (339.7) | (230.0) | (151.8) | 26.2 | (71.4) | (57.5) | (75.9) | (62.0) | (43.8) | (20.5) | (21.3) | (8.6) | (8.7) | (9.6) |
| Net Income | (285.4) | (318.8) | (209.4) | (149.3) | 24.9 | (73.1) | (56.0) | (74.0) | (60.8) | (44.5) | (24.1) | (19.8) | (14.2) | (10.0) | (13.1) |
| EPS (Diluted) | -3.29 | -3.73 | -2.98 | -2.46 | 0.48 | -1.77 | -1.84 | -2.92 | -2.90 | -3.04 | -4.31 | -2.07 | -1.77 | -0.14 | – |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 134.9 | 154.1 | 295.4 | 74.4 | 222.0 | 115.2 | 24.6 | 33.8 | 35.2 | 23.8 | |||||
| Total Assets | 529.7 | 724.8 | 612.9 | 497.2 | 449.7 | 300.6 | 63.5 | 83.9 | 137.2 | 109.0 | |||||
| Total Debt | 346.5 | 345.7 | 1.6 | 1.2 | 21.0 | 20.5 | 0.9 | 0 | 0 | 0 | |||||
| Stockholders' Equity | 64.6 | 288.1 | 554.2 | 467.4 | 408.4 | 252.2 | 31.6 | 53.0 | 104.3 | 84.1 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | (323.0) | (274.9) | (160.6) | (133.7) | 29.1 | (71.3) | (50.6) | (68.5) | (47.4) | (35.2) | |||||
| Capital Expenditure | (0.2) | 0 | 0 | (0.2) | (0.1) | 0 | 0 | (0.2) | (0.1) | (0.3) | |||||
| Free Cash Flow | (323.2) | (274.9) | (160.6) | (133.9) | 29.0 | (71.3) | (50.6) | (68.7) | (47.5) | (35.4) | |||||